A carregar...

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes

Pharmaceutical agonists of peroxisome proliferator-activated receptors (PPARs) are widely used in the management of type 2 diabetes, chiefly as lipid-lowering agents and oral hypoglycaemic agents. Although most of the focus has been placed on their cardiovascular effects, both positive and negative,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Thomas, M. C., Jandeleit-Dahm, K. A., Tikellis, C.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3289856/
https://ncbi.nlm.nih.gov/pubmed/22448165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/456529
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!